Benchmarking scatterplot for non-ICU units.

Slides:

Advertisements

Similar presentations

Improved Glucose Control With Weight Loss, Lower Insulin Doses, and No Increased Hypoglycemia With Empagliflozin Added to Titrated Multiple Daily Injections.

Advertisements

Copyright © 2015 by the American Osteopathic Association.

Components of a CGM record over a 3

Modulation of the intensiveness of glucose lowering in type 2 diabetes

Volume 70, Issue 8, Pages (October 2006)

A: Percentage of type 1 diabetic and type 2 diabetic patients with asymptomatic hypoglycemias detected by the CGMS. B: Daily distribution of asymptomatic.

Rank-order bar chart of percentage of patient-days with blood glucose results > 299 mg/dl for non-ICU units. Rank-order bar chart of percentage of patient-days.

George Dailey, MD Mayo Clinic Proceedings

Summary of DURATION development program select efficacy results: absolute difference in change in A1C, body weight, systolic blood pressure, and LDL cholesterol.

Insulin and glucagon secretion: nondiabetic and diabetic subjects.

Practical diagram of typical insulin dose requirements for type 1, type 2, and other forms of diabetes mellitus. Practical diagram of typical insulin dose.

Depiction of the elements of decision making used to determine appropriate efforts to achieve glycemic targets. Depiction of the elements of decision making.

Continuous glucose monitoring tracings of two patients with type 1 diabetes (one patient per panel) on a day when aerobic exercise was performed (open.

Fig. 1. Glycemic variability in three hypothetical patients who have the same mean blood glucose concentration. Patient B has relatively small variations.

Depicted are patient and disease factors used to determine optimal A1C targets. Depicted are patient and disease factors used to determine optimal A1C.

Severe hypoglycemia after initiation of anti–tumor necrosis factor therapy with etanercept in a patient with generalized pustular psoriasis and type 2.

PWD confidence with key diabetes management activities.

PWD who regularly or occasionally engaged in activities to manage their diabetes. PWD who regularly or occasionally engaged in activities to manage their.

Flowchart of literature search for the effect of fructose on glycemic end points (fasting glucose, fasting insulin, and glycated blood proteins [HbA1c.

The means and SDs of the data from all Glucommander runs from 1984 to 1998 are graphed. The means and SDs of the data from all Glucommander runs from 1984.

Modern Advances in Glucose Monitoring

The ETS-CRE array identifies genomic sequences specifically cobound by CREB1 and GABPα. The ETS-CRE array identifies genomic sequences specifically cobound.

Frequency of potential risk of hypoglycemia for each estimate method, defined as a percentage difference between the estimate and final basal rate. Frequency.

Time-course changes in blood glucose (BG; A), C peptide (B), and non-esterified fatty acid (NEFA; C) levels. Time-course changes in blood glucose (BG;

Respondents’ perceptions on (A) the potential of IDegLira compared with basal-bolus therapy to improve patient motivation to reach their target blood glucose.

Mean daily glucose concentration and frequency of hypoglycemia in long-term care residents with type 2 diabetes. Mean daily glucose concentration and frequency.

Model of deterioration over time and potential interventions to identify and mitigate. Model of deterioration over time and potential interventions to.

Anna Björkenheim et al. JACEP 2017;j.jacep

Hospital-level procedural sedation rates among pediatric patients in the earliest year, (2009, red circle) and the most recent year (2014, blue bar). Hospital-level.

Scatterplot showing the association between baseline weight and weight change at 1 year, relative to baseline for each treatment group. Scatterplot showing.

Catherine M. Pound et al. Hospital Pediatrics 2017;7:

Simplified Markov diagram of a patient admitted to the ward with no respiratory support. Simplified Markov diagram of a patient admitted to the ward with.

Anna Björkenheim et al. JACEP 2017;j.jacep

An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61

Overexpression of BTG2 resulted in an increase in hepatic gluconeogenesis. Overexpression of BTG2 resulted in an increase in hepatic gluconeogenesis. A:

Serial measurements of serum glucose, anion gap, serum carbon dioxide, and serum triglycerides throughout the patient's hospital stay. Serial measurements.

Association between hospital-level diagnostic testing and admission percentage for patients with AGE at 34 US children’s hospitals. Association between.

The rates of occurrences of cardiovascular, cerebrovascular, and all events expressed in cases per 1, 000 patient-years in diabetic subgroups divided by.

Mean (95% CI) fasting s-glucose at baseline and 6-month, 12-month, and 24-month follow-up, overall and by sex (A), and by baseline age (B), education (C),

(A) Glucose values (mean +SEM) during continuous glucose monitoring while consuming whey protein (solid lines and filled circles) or placebo (broken lines.

Exogenous CRP administration causes fasting hyperglycemia and hyperinsulinemia without altering body composition. Exogenous CRP administration causes fasting.

Percentage of patients with type 2 diabetes with A1C < 7% (n = 248), blood pressure > 130/80 mmHg (n = 248), and LDL cholesterol < 100 mg/dl (n = 207)

An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61

Relationship between blood cell and plasma miRNA expression among published circulating cancer biomarkers. Relationship between blood cell and plasma miRNA.

Mean LOS and 30-day all-cause readmission rates before and after conversion to the Interdisciplinary Diabetes Care model. Mean LOS and 30-day all-cause.

Intrapatient variability in cyclosporine blood levels in renal transplant patients. Intrapatient variability in cyclosporine blood levels in renal transplant.

Whole-brain, voxel-based correlation analyses with leptin.

Baroreflex function measured by the modified Oxford method during baseline euglycemia (circles) and hypoglycemia (triangles). Baroreflex function measured.

Rapid improvement of glucose tolerance induced by PP

Mean (±SE) plasma glucose concentrations before, during, and after infusions of octreotide (with growth hormone) with saline (•), with insulin replacement.

Mean decline in grip strength with aging is shown for participants categorized by baseline quartile of 2 h glucose (2HG). Mean decline in grip strength.

Oral glucose tolerance testing during hospitalization and at 4 months after infarction. Oral glucose tolerance testing during hospitalization and at 4 months.

Blood glucose levels in chicken embryos.

Proportion of patients experiencing documented symptomatic hypoglycemia (blood glucose

Metabolic parameters in the three groups of patients during l-arginine infusion. Metabolic parameters in the three groups of patients during l-arginine.

Meal control achieved in the five meals of the study (the first dinner was handled in open-loop mode, and all other meals were handled by closed-loop).

Glycemic control and body weight over 52 weeks.

Protocol for Management of Adult Patients with Diabetic Ketoacidosis

(A) Mean glucose concentrations (standard error) over a 3-hour period in 21 placebo- and 15 pramlintide-treated patients with type 1 diabetes treated for.

Maria R. Costanzo et al. JCHF 2016;4:

Postoperative blood glucose levels and total insulin requirement.

Pathway to initial antihypertensive therapy in patients with diabetes

Glycemic control in Hispanic and non-Hispanic patients during the SWITCH 2 trial. Glycemic control in Hispanic and non-Hispanic patients during the SWITCH.

Upper panel: For performance of the 10-g monofilament test, the device is placed perpendicular to the skin, with pressure applied until the monofilament.

The primary axis scores of each sample from a constrained ordination of principal coordinates (CAP) for the temperature profile of each city are indicated.

Elevated blood glucose vs time.

Kaplan-Meier curve of the primary outcome in patients prescribed ACE inhibitor (ACEI) and angiotensin receptor blocker (ARB). Kaplan-Meier curve of the.

Novel presentation of glucose data from a patient with type 1 diabetes

Schematic diagram of the concept of hypoglycemia-associated autonomic failure and the pathogenesis of the syndromes of defective glucose counterregulation.

ERRs (degludec/glargine U100) of hypoglycemia in Hispanic and non-Hispanic patients during the SWITCH 2 trial. ERRs (degludec/glargine U100) of hypoglycemia.

Presentation transcript:

Benchmarking scatterplot for non-ICU units. Benchmarking scatterplot for non-ICU units. Each hospital is depicted by its number and its position, defined by its performance for glycemic control (day-weighted mean glucose) on the y-axis, and hypoglycemia rates per patient-day on the x-axis. Quartiles of performance are depicted by the broken lines, with the top performers in the left lower quadrant attaining the best quartile of performance for both hyper- and hypoglycemia rates. The red color highlights an individual hospital's performance. BG, blood glucose. Greg Maynard et al. Diabetes Spectr 2014;27:212-217 ©2014 by American Diabetes Association